Informing forecasting and epidemiology analyses for oncology tumors
A world-leading biotechnology company sought to understand epidemiology and subpopulation assumptions across a number of countries for various oncology tumor types
The intent of the reports was to support marketing and disease teams in their market analysis and inform forecasting efforts for core pipeline agents
Opus analyzed epidemiology data across numerous proprietary and public sources, carefully vetting and comparing study methodologies
Opus leveraged the data to create detailed patient segmentation charts that documented diagnosed prevalence, splits by disease severity, and proportion of patients eligible for various lines of therapy, etc.
Opus tracked shifting treatment algorithms and patient segments by region
Our client used these reports to apprise their marketing and disease teams of fundamental market opportunities in order to inform future go-to-market strategy.